GB9920906D0 - Increased production of interferon-a - Google Patents

Increased production of interferon-a

Info

Publication number
GB9920906D0
GB9920906D0 GBGB9920906.6A GB9920906A GB9920906D0 GB 9920906 D0 GB9920906 D0 GB 9920906D0 GB 9920906 A GB9920906 A GB 9920906A GB 9920906 D0 GB9920906 D0 GB 9920906D0
Authority
GB
United Kingdom
Prior art keywords
interferon
increased production
production
increased
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9920906.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9920906.6A priority Critical patent/GB9920906D0/en
Publication of GB9920906D0 publication Critical patent/GB9920906D0/en
Priority to PCT/GB2000/003367 priority patent/WO2001018039A2/en
Priority to AU68581/00A priority patent/AU6858100A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9920906.6A 1999-09-03 1999-09-03 Increased production of interferon-a Ceased GB9920906D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9920906.6A GB9920906D0 (en) 1999-09-03 1999-09-03 Increased production of interferon-a
PCT/GB2000/003367 WO2001018039A2 (en) 1999-09-03 2000-09-01 INCREASED PRODUCTION OF INTERFERON-$g(a)
AU68581/00A AU6858100A (en) 1999-09-03 2000-09-01 Increased production of interferon-alpha

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920906.6A GB9920906D0 (en) 1999-09-03 1999-09-03 Increased production of interferon-a

Publications (1)

Publication Number Publication Date
GB9920906D0 true GB9920906D0 (en) 1999-11-10

Family

ID=10860342

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9920906.6A Ceased GB9920906D0 (en) 1999-09-03 1999-09-03 Increased production of interferon-a

Country Status (3)

Country Link
AU (1) AU6858100A (en)
GB (1) GB9920906D0 (en)
WO (1) WO2001018039A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015524397A (en) 2012-07-20 2015-08-24 ラトローブ ユニヴァーシティ Methods of diagnosis and treatment
GB201505382D0 (en) 2015-03-29 2015-05-13 Svanborg Catharina Novel therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626448A3 (en) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Process for preparing and purifying alpha-interferon
CA2234588A1 (en) * 1998-04-07 1999-10-07 John Hiscott Virus induced phosphorylation of interferon regulatory factor-3

Also Published As

Publication number Publication date
AU6858100A (en) 2001-04-10
WO2001018039A3 (en) 2001-05-25
WO2001018039A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
GB9925136D0 (en) Novel treatment
HUP0202519A3 (en) Production of proteins
IL146510A0 (en) Production of complex carbohydrates
IL144186A0 (en) Novel treatment
EP1218407A4 (en) Uses of kappa-conotoxin pviia
GB9924855D0 (en) Novel processes
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
GB9920906D0 (en) Increased production of interferon-a
EG22789A (en) Production valve
EP1242378A4 (en) Novel processes
GB9802487D0 (en) Production of heptafluoropane
GB2349159B (en) Bricks
GB2356551B (en) Locket
TW406777U (en) Structure of lighting set
TW468411U (en) Structure of cardcase
TW394123U (en) Structure of emery-roller
GB9920641D0 (en) Gnosis - The game of understanding
HU9900075V0 (en) Sepulchre consists of elements
TW399438U (en) Improved structure of bedhead
TW459861U (en) Structure of plastic form
TW389046U (en) Structure of hairgrip combinations
GB9927259D0 (en) Shaping of materials
TW429799U (en) Structure of top
TW429744U (en) Improved structure of pants
TW391279U (en) Structural improvement of football

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)